Thomas Jefferson University Hospital (Sidney Kimmel Cancer Center at Jefferson) Is Ranked No. 20 in the Nation in the Cancer Specialty, According to US News and World Report

Published: Monday, Aug 14, 2017

According to new rankings released today from US News & World Report, Thomas Jefferson University Hospital (Sidney Kimmel Cancer Center at Jefferson) is ranked in the cancer specialty as No. 20 in the nation for 2017-2018. This ranking is up from the 2016-2017 ranking of 29, further raising the profile of Center City Philadelphia’s only National Cancer Institute (NCI)-designated Cancer Center. US News & World Report Best Hospitals rankings recognize hospitals that treat the most challenging patients, and evaluate each hospital’s use of advanced technologies, safety, outcomes, and capacity to overcome other medical issues.

The Sidney Kimmel Cancer Center at Jefferson first achieved NCI designation in 1996. As part of Thomas Jefferson University Hospital, it has been consecutively ranked by US News & Report amongst the top 50 national Cancer Centers since 2008.

“Thomas Jefferson University Hospital (Sidney Kimmel Cancer Center at Jefferson) is honored to be ranked by US News & World Report as No. 20 in the nation for the cancer specialty”, said Dr. Karen E. Knudsen, Director of the Sidney Kimmel Cancer Center at Jefferson. “This recognition comes as we have enhanced the pace of cancer research and capacity to translate discoveries into promising new methods for cancer prevention, detection, and treatment. We are now engaging in new approaches to deliver advanced cancer care to the community setting, through our Cancer Care 360 initiative”.

Factors that influenced Thomas Jefferson University Hospital’s exceptional ranking in the cancer specialty include nurse Magnet status, capacity to treat cancer patients with underlying previous or complicated conditions, and continued superior scores for outcomes.

The national ranking for cancer for Thomas Jefferson University Hospital (Sidney Kimmel Cancer Center at Jefferson) contributed to overall exceptional ranking for Thomas Jefferson University Hospital, which is named 16th on U.S. News & World Report’s 2017-2018 Best Hospitals Honor Roll. "We are all proud of the clinicians and staff who ensured we ranked No. 20 in the cancer specialty in the nation, as well as the 16th ranked hospital," said Stephen K. Klasko, MD, MBA, President and CEO of Thomas Jefferson University and Jefferson Health. 

"The ranking speaks to our strategic commitment to improving health and longevity for the communities of Greater Philadelphia. Thanks to our scientists, we are leaders in using molecular testing to assess cancer risk. As a result, we can match patients to the most effective treatment regimens and attack racial disparities in mortality. Further, with our adoption of Cancer Care 360, we will be a top 20 cancer center that is always within reach."

About SKCC

A leading center for practice-changing discovery and comprehensive cancer treatment, the Sidney Kimmel Cancer Center of the Thomas Jefferson University has been known as a Designated Center by the National Cancer Institute since 1996, and is one of only 69 institutions in the nation to hold this prestigious recognition. SKCC is committed to delivering the most advanced, personalized cancer care, made possible through their scientific discoveries and breakthroughs in detecting and treating cancer. SKCC provides access to advanced clinical trials and novel treatment strategies throughout the Greater Delaware Valley, realized through our integral sites in Center City Philadelphia, Abington, Aria, and the comprehensive, Sidney Kimmel Cancer Center Network. Routinely ranked amongst the top hospitals for cancer care in the United States by US News & World Report, the multi-disciplinary teams at SKCC bring together specialists for treatment planning, which results in some of the highest survival rates in the nation

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®Apr 30, 20192.0
Oncology Consultations®: The Advancing Role of CAR T-Cell Therapies in Hematologic MalignanciesApr 30, 20191.5
Publication Bottom Border
Border Publication